3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Genitourinary
1
Endocrine
1
Breast
1
Conditions
Breast Neoplasms
25
Neoplasms
5
Prostatic Neoplasms
4
Neoplasm Metastasis
3
Multiple Myeloma
2
Thyroid Neoplasms
1
Parathyroid Neoplasms
1
Osteoporotic Fractures
1
Osteoporosis
1
Osteopetrosis, mild autosomal recessive form
1
Osteopetrosis, Autosomal Recessive 7
1
Neoplastic Cells, Circulating
1
Musculoskeletal Pain
1
Lymphoma, Non-Hodgkin
1
Lymphoma
1
Lung Neoplasms
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hypercalcemia
1
Humoral Hypercalcemia Of Malignancy
1
Hodgkin Disease
1
Head and Neck Neoplasms
1
Fractures, Bone
1
Endocrine Gland Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Ductal, Breast
1
Breast Diseases
1
Bone Diseases, Metabolic
1
Arthralgia
1
Interventions
Zoledronic Acid
8
Letrozole
7
Risedronic Acid
6
Vitamin D
4
Absorptiometry, Photon
4
Calcium
3
Progesterone
2
Hormone Replacement Therapy
2
Cholecalciferol
2
Calcium Carbonate
2
Aromatase Inhibitors
2
Anastrozole
2
xian ling gu bao
1
Testosterone
1
Spectrum Analysis
1
Raloxifene Hydrochloride
1
Progestins
1
Linseed Oil
1
Exercise Movement Techniques
1
Estrogens, Conjugated (USP)
1
Estrogens
1
Estrogen Replacement Therapy
1
Estradiol
1
Diphosphonates
1
Dietary Supplements
1
Diet, Fat-Restricted
1
Denosumab
1
Calcium Gluconate
1
Calcium Citrate
1
Bone Density
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteoporosis
×
Denosumab
×
Breast
×
Clear all
NCT03811509
2019-01-28
B-ABLE
Parc de Salut Mar
Phase 4
Unknown
1,000 enrolled